
Novel RORγt ингибитор, suppressing Th17 клетка differentiation, reducing the severity of experimental autoimmune disease models such as EAU, EAE, and type 1 diabetes
Novel RORγt inhibitor, suppressing Th17 cell differentiation, reducing the severity of experimental autoimmune disease models such as EAU, EAE, and type 1 diabetes
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.